Replies to post #43418 on Cytogenix (fka CYGX)

[HANUMAN]

Marcus, doesn't this qualify as a peer reviewed article?

CytoGenix Antibacterial Discovery Published in Medical Research Journal
Houston, TX, (March 23, 2005) Cytogenix, Inc. (CYGX: OTC: BB)

CytoGenix, Inc. (CYGX: OTC: BB) announced today that a manuscript reporting the results of studies conducted by Dr. Yin Chen, Vice President of R & D and Dr. Xin-Xing Tan, Senior Scientist was accepted for publication in the respected scientific journal Biochemistry. This paper reports the successful use of the company's proprietary cell-based DNA screening and targeting method to discover novel antibacterial compounds and potential drug-susceptible molecular targets.

Drs. Chen and Tan's paper titled, "A Novel Genomic Approach Identifies Bacterial DNA-Dependent RNA Polymerase as the Target of an Antibacterial Oligodeoxynucleotide, RBL1" will be published in an upcoming issue of the American Chemical Society's, journal Biochemistry. "The purpose of Biochemistry is to publish the results of original research that contribute significantly to the understanding of the mechanism of biological phenomena in terms of molecular structure and/or function. Biochemistry investigates the rapidly changing arena where chemistry, biochemistry and molecular and cell biology interrelate."